NCT04973163 2026-02-17A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS MutationBoehringer IngelheimPhase 1 Active not recruiting30 enrolled